Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform rating. Why Oppenheimer Is Bullish on ALMS Due to concerns about Alumis’ cash ...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Exxon Mobil Corp (Symbol: XOM), where a total of 77,941 contracts have traded so far, ...
Alumis Inc. (NASDAQ:ALMS) is one of the new stocks on the rise. On January 21, Chardan initiated coverage of Alumis with a Buy rating and a $37 price target driven by the significant potential of the ...
Hosted on MSN
Why Alumis Inc. (ALMS) Went Down On Thursday?
We recently published a list of Thursday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where Alumis Inc. (NASDAQ:ALMS) stands against other Thursday’s worst-performing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results